100 related articles for article (PubMed ID: 4052954)
1. Natural killer cell activity during the course of disease in patients with Hodgkin's disease.
Frydecka I
Cancer; 1985 Dec; 56(12):2799-803. PubMed ID: 4052954
[TBL] [Abstract][Full Text] [Related]
2. Natural killer (NK) activity in patients with Hodgkin's disease before, during and after multiple-agent therapy.
Frydecka I; Kotlarek-Haus S; Kuliszkiewicz-Janus M; Kuliczkowski K
Arch Immunol Ther Exp (Warsz); 1990; 38(5-6):407-14. PubMed ID: 2130805
[TBL] [Abstract][Full Text] [Related]
3. Normal natural killer cell activity in Hodgkin's disease patients in remission.
Douer D; Shaked N; Ramot B
Clin Exp Immunol; 1987 Sep; 69(3):660-7. PubMed ID: 3665188
[TBL] [Abstract][Full Text] [Related]
4. Interferon enhanced natural killer function in Hodgkin's disease.
Levy S; Reins F; Aleksijevic A; Giron C; Oberling F; Mayer S; Lang JM
Nouv Rev Fr Hematol (1978); 1986; 28(5):323-5. PubMed ID: 3808943
[TBL] [Abstract][Full Text] [Related]
5. Low natural killer cell activity in patients with malignant lymphoma.
Tursz T; Dokhelar MC; Lipinski M; Amiel JL
Cancer; 1982 Dec; 50(11):2333-5. PubMed ID: 6958348
[TBL] [Abstract][Full Text] [Related]
6. Surface markers and cytotoxic activity of blood natural killer cells studied at the single cell level in Hodgkin's disease.
Jezewska E; Björkholm M; Giscombe R; Holm G; Tullgren O
Clin Exp Immunol; 1985 Jul; 61(1):96-102. PubMed ID: 4042422
[TBL] [Abstract][Full Text] [Related]
7. In vitro radiosensitivity of the spontaneous cytotoxicity of blood lymphocytes in patients with untreated Hodgkin's disease.
Rotstein S; Baral E; Blomgren H; Johansson B
Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1405-9. PubMed ID: 6685629
[TBL] [Abstract][Full Text] [Related]
8. Heat shock protein 90 inhibitor BIIB021 (CNF2024) depletes NF-kappaB and sensitizes Hodgkin's lymphoma cells for natural killer cell-mediated cytotoxicity.
Böll B; Eltaib F; Reiners KS; von Tresckow B; Tawadros S; Simhadri VR; Burrows FJ; Lundgren K; Hansen HP; Engert A; von Strandmann EP
Clin Cancer Res; 2009 Aug; 15(16):5108-16. PubMed ID: 19671844
[TBL] [Abstract][Full Text] [Related]
9. Natural killer (NK) activity in the spleen of patients with Hodgkin's disease and controls.
Al Sam S; Jones DB; Payne SV; Wright DH
Br J Cancer; 1982 Nov; 46(5):806-10. PubMed ID: 7171458
[No Abstract] [Full Text] [Related]
10. [Cytotoxic activity of K-lymphocytes (killer cells) in Hodgkin's disease].
Górska B; Konopka L; Seyfried H; Pawelski S
Pol Tyg Lek; 1980 Aug; 35(33):1249-51. PubMed ID: 7433209
[No Abstract] [Full Text] [Related]
11. The difference in NK-cell activity between patients with non-Hodgkin's lymphomas and Hodgkin's disease.
Konjević G; Jurisić V; Banićevic B; Spuzić I
Br J Haematol; 1999 Jan; 104(1):144-51. PubMed ID: 10027727
[TBL] [Abstract][Full Text] [Related]
12. Depressed NK cell activity of peripheral blood mononuclear cells in untreated hodgkin's disease: enhancing effect of interferon in vitro.
Levy S; Tempe JL; Aleksijevic A; Giron C; Oberling F; Mayer S; Lang JM
Scand J Haematol; 1984 Oct; 33(4):386-90. PubMed ID: 6209786
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic and functional analysis of expanded natural killer cell subpopulations in Hodgkin's disease patients treated with lymphoid irradiation.
Macklis RM; Mauch PM; Thompson L; Burakoff SJ; Smith BR
Oncology; 1993; 50(4):323-8. PubMed ID: 8497384
[TBL] [Abstract][Full Text] [Related]
14. Natural killer activity in spleens and lymph nodes from patients with Hodgkin's disease.
Ruco LP; Procopio A; Uccini S; Marcorelli E; Baroni CD
Cancer Res; 1982 May; 42(5):2063-8. PubMed ID: 6175405
[TBL] [Abstract][Full Text] [Related]
15. Reduced natural killer cell activity in non-hodgkin's lymphoma.
Neri A; Brugiatelli M; Ozger Topuz U; Astaldi G
Boll Ist Sieroter Milan; 1981 Nov; 60(5):394-407. PubMed ID: 7041921
[TBL] [Abstract][Full Text] [Related]
16. In vitro modulation of natural killer cell activity in non-Hodgkin's lymphoma patients after therapy.
Mehta BA; Satam MN; Advani SH; Nadkarni JJ
Cancer Immunol Immunother; 1989; 28(2):148-52. PubMed ID: 2917365
[TBL] [Abstract][Full Text] [Related]
17. Increased number of functionally defective large granular lymphocytes in lymphoma patients.
Muhonen T; Teerenhovi L; Saksela E
Nat Immun Cell Growth Regul; 1987; 6(2):57-64. PubMed ID: 3600676
[TBL] [Abstract][Full Text] [Related]
18. Natural killer cell numbers and cytotoxic activity in pediatric Hodgkin disease.
Ikincioğullari A; Doğu F; Babacan E; Oflaz G; Ertem U; Yavuz G; Unal E; Gözdaşoğlu S; Taçyildiz N; Dağdemir A; Cavdar AO
Pediatr Hematol Oncol; 2000 Mar; 17(2):133-9. PubMed ID: 10734655
[TBL] [Abstract][Full Text] [Related]
19. Natural killer and lymphokine activated killer cell functions in Hodgkin's disease.
Rajaram N; Tatake RJ; Advani SH; Gangal SG
Br J Cancer; 1990 Aug; 62(2):205-8. PubMed ID: 2386735
[TBL] [Abstract][Full Text] [Related]
20. [Activity of natural cytotoxic cells in non-Hodgkin's lymphoma].
Frydecka I; Kotlarek-Haus S; Kuliczkowski K; Kuliszkiewicz-Janus M
Pol Tyg Lek; 1992 Apr 20-27; 47(16-17):357-9. PubMed ID: 1437753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
